Connection
Susan Lana to Retrospective Studies
This is a "connection" page, showing publications Susan Lana has written about Retrospective Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.147 |
|
|
|
-
Selmic LE, Lafferty MH, Kamstock DA, Garner A, Ehrhart NP, Worley DR, Withrow SJ, Lana SE. Outcome and prognostic factors for osteosarcoma of the maxilla, mandible, or calvarium in dogs: 183 cases (1986-2012). J Am Vet Med Assoc. 2014 Oct 15; 245(8):930-8.
Score: 0.029
-
Selmic LE, Burton JH, Thamm DH, Withrow SJ, Lana SE. Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma. J Vet Intern Med. 2014 Mar-Apr; 28(2):554-63.
Score: 0.028
-
Mullins MN, Dernell WS, Withrow SJ, Ehrhart EJ, Thamm DH, Lana SE. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004). J Am Vet Med Assoc. 2006 Jan 01; 228(1):91-5.
Score: 0.016
-
Hillers KR, Dernell WS, Lafferty MH, Withrow SJ, Lana SE. Incidence and prognostic importance of lymph node metastases in dogs with appendicular osteosarcoma: 228 cases (1986-2003). J Am Vet Med Assoc. 2005 Apr 15; 226(8):1364-7.
Score: 0.015
-
Lana SE, Dernell WS, Lafferty MH, Withrow SJ, LaRue SM. Use of radiation and a slow-release cisplatin formulation for treatment of canine nasal tumors. Vet Radiol Ultrasound. 2004 Nov-Dec; 45(6):577-81.
Score: 0.015
-
Nolan MW, Uzan OC, Green NA, Lana SE, Lascelles BDX. Intensity of perioperative analgesia but not pre-treatment pain is predictive of survival in dogs undergoing amputation plus chemotherapy for extremity osteosarcoma. Vet Comp Oncol. 2022 Sep; 20(3):568-576.
Score: 0.012
-
Lana SE, Ogilvie GK, Withrow SJ, Straw RC, Rogers KS. Feline cutaneous squamous cell carcinoma of the nasal planum and the pinnae: 61 cases. J Am Anim Hosp Assoc. 1997 Jul-Aug; 33(4):329-32.
Score: 0.009
-
Miller AG, Morley PS, Rao S, Avery AC, Lana SE, Olver CS. Anemia is associated with decreased survival time in dogs with lymphoma. J Vet Intern Med. 2009 Jan-Feb; 23(1):116-22.
Score: 0.005
-
Williams MJ, Avery AC, Lana SE, Hillers KR, Bachand AM, Avery PR. Canine lymphoproliferative disease characterized by lymphocytosis: immunophenotypic markers of prognosis. J Vet Intern Med. 2008 May-Jun; 22(3):596-601.
Score: 0.005
-
Hillers KR, Lana SE, Fuller CR, LaRue SM. Effects of palliative radiation therapy on nonsplenic hemangiosarcoma in dogs. J Am Anim Hosp Assoc. 2007 Jul-Aug; 43(4):187-92.
Score: 0.004
-
Williams LE, Rassnick KM, Power HT, Lana SE, Morrison-Collister KE, Hansen K, Johnson JL. CCNU in the treatment of canine epitheliotropic lymphoma. J Vet Intern Med. 2006 Jan-Feb; 20(1):136-43.
Score: 0.004
-
Williams LE, Gliatto JM, Dodge RK, Johnson JL, Gamblin RM, Thamm DH, Lana SE, Szymkowski M, Moore AS. Carcinoma of the apocrine glands of the anal sac in dogs: 113 cases (1985-1995). J Am Vet Med Assoc. 2003 Sep 15; 223(6):825-31.
Score: 0.003
-
Kristal O, Lana SE, Ogilvie GK, Rand WM, Cotter SM, Moore AS. Single agent chemotherapy with doxorubicin for feline lymphoma: a retrospective study of 19 cases (1994-1997). J Vet Intern Med. 2001 Mar-Apr; 15(2):125-30.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|